Glymidine sodium - Misplaced Pages

Chemical compound Pharmaceutical compound

Glycodiazine
Clinical data

Routes of administration	Oral
ATC code	A10BC01 (WHO)
Pharmacokinetic data
Bioavailability	High
Protein binding	90%
Elimination half-life	3.8 hours
Identifiers
IUPAC name N-benzenesulfonamide
CAS Number	339-44-6
PubChem CID	9565
DrugBank	DB01382
ChemSpider	9190
UNII	4C5I4BQZ8F
ChEBI	CHEBI:31660
ChEMBL	ChEMBL1697838
CompTox Dashboard (EPA)	DTXSID1023108
ECHA InfoCard	100.005.842
Chemical and physical data
Formula	C₁₃H₁₅N₃O₄S
Molar mass	309.34 g·mol
3D model (JSmol)	Interactive image
SMILES O=S(=O)(Nc1ncc(OCCOC)cn1)c2ccccc2
InChI InChI=1S/C13H15N3O4S/c1-19-7-8-20-11-9-14-13(15-10-11)16-21(17,18)12-5-3-2-4-6-12/h2-6,9-10H,7-8H2,1H3,(H,14,15,16) Key:QFWPJPIVLCBXFJ-UHFFFAOYSA-N
(what is this?) (verify)

Glymidine sodium (INN, also known as glycodiazine; trade name Gondafon) is a sulfonamide antidiabetic drug, structurally related to the sulfonylureas. It was first reported in 1964, and introduced to clinical use in Europe in the mid to late 1960s.

References

"Glymidine". British Medical Journal. 2 (5555): 817. June 1967. doi:10.1136/bmj.2.5555.817. PMC 1843097. PMID 6029147.

This drug article relating to the gastrointestinal system is a stub. You can help Misplaced Pages by expanding it.

Categories: